The typical application of radiomics methods in glioblastoma imaging is a differential diagnosis (with other tumors, pseudoprogression), survival prognosis in general life expectancy, identification of molecular biomarkers (for example, IDH1, MGMT) [10]. The gene discussed is IDH1; the disease is glioblastoma.